Femme et Homme
- | Pays :
- Croatia
- Czech Republic
- Russian Federation
- Les 4 autres...
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to assess the reduction of systemic inflammation as measured by serum levels of C-reactive protein (CRP). The secondary objectives are: - to assess the reduction of systemic inflammation as measured changes in acute phase protein, serum amyloid A (SAA) and cytokine interleukin-6 (IL-6), and clinical American College of Rheumatology response rate, and morning stiffness duration; - to assess the effect on pain relief within first 14 days; - to obtain evidence of the safety and tolerability of SSR150106; - to document trough plasma levels of SSR150106 and its first metabolite.
Critère d'inclusion
- Rheumatoid Arthritis